EQ
EQ
NASDAQ · Biotechnology

Equillium Inc

$1.42
-0.04 (-2.41%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 17 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +1,798.6% upside
Low Target $18.17
Average Target $26.96
High Target $35.46
Current Price $1.42
Current
$1.42
Target
$26.96
$18.17 $26.96 avg $35.46
Scenario Analysis
Bear Case
$18.17
1,179.6%
Low target
Base Case
$26.96
+1,798.6%
Avg target
Bull Case
$35.46
+2,397.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.54
-59.9% from high
52-Week Low
$0.76
+86.8% from low
Target vs 52W High
$26.96
+661.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%